Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Generation, Detection, and Effects of Reactive Drug Metabolites
Andrew V. Stachulski, Thomas A. Baillie, B. Kevin Park, et al.
Medicinal Research Reviews (2012) Vol. 33, Iss. 5, pp. 985-1080
Closed Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models
Richard Weaver, Eric A.G. Blomme, Amy E. Chadwick, et al.
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 2, pp. 131-148
Open Access | Times Cited: 190
Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five
Caroline Manto Chagas, Sara Moss, Laleh Alisaraie
International Journal of Pharmaceutics (2018) Vol. 549, Iss. 1-2, pp. 133-149
Closed Access | Times Cited: 183
Structure-Based Virtual Screening Approach for Discovery of Covalently Bound Ligands
Dora Toledo Warshaviak, G. Golan, Kenneth Borrelli, et al.
Journal of Chemical Information and Modeling (2014) Vol. 54, Iss. 7, pp. 1941-1950
Closed Access | Times Cited: 139
Reactive Metabolites: Current and Emerging Risk and Hazard Assessments
Richard A. Thompson, Emre M. Isin, Monday O. Ogese, et al.
Chemical Research in Toxicology (2016) Vol. 29, Iss. 4, pp. 505-533
Closed Access | Times Cited: 126
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107
Predicting Toxicities of Reactive Metabolite–Positive Drug Candidates
Amit S. Kalgutkar, Deepak Dalvie
The Annual Review of Pharmacology and Toxicology (2014) Vol. 55, Iss. 1, pp. 35-54
Closed Access | Times Cited: 104
Mechanisms of drug-induced liver injury
Camilla Stephens, Raúl J. Andrade, M. Isabel Lucena
Current Opinion in Allergy and Clinical Immunology (2014) Vol. 14, Iss. 4, pp. 286-292
Closed Access | Times Cited: 102
Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network
Tyler B. Hughes, Na Le Dang, Grover P. Miller, et al.
ACS Central Science (2016) Vol. 2, Iss. 8, pp. 529-537
Open Access | Times Cited: 93
Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid
Alison J. Foster, Bhavik Chouhan, Sophie Regan, et al.
Archives of Toxicology (2019) Vol. 93, Iss. 4, pp. 1021-1037
Open Access | Times Cited: 89
Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies
Bryan H. Norman
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 20, pp. 11397-11419
Closed Access | Times Cited: 84
Preparative Microfluidic Electrosynthesis of Drug Metabolites
Romain Stalder, Gregory P. Roth
ACS Medicinal Chemistry Letters (2013) Vol. 4, Iss. 11, pp. 1119-1123
Open Access | Times Cited: 90
Mechanisms of soft and hard electrophile toxicities
Richard M. LoPachin, Brian C. Geohagen, Lars Ulrik Nordstroem
Toxicology (2019) Vol. 418, pp. 62-69
Open Access | Times Cited: 68
Drug metabolism and metabolite safety assessment in drug discovery and development
Chunyong He, Hong Wan
Expert Opinion on Drug Metabolism & Toxicology (2018) Vol. 14, Iss. 10, pp. 1071-1085
Closed Access | Times Cited: 67
Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism
Tyler B. Hughes, S. Joshua Swamidass
Chemical Research in Toxicology (2017) Vol. 30, Iss. 2, pp. 642-656
Open Access | Times Cited: 66
INTEDE 2.0: the metabolic roadmap of drugs
Yang Zhang, Xingang Liu, Fengcheng Li, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1355-D1364
Open Access | Times Cited: 18
Glutathione and glutathione disulfide – their biomedical and pharmaceutical applications
Xiangming Guan
Medicinal Chemistry Research (2023) Vol. 32, Iss. 9, pp. 1972-1994
Closed Access | Times Cited: 17
Chemical metabolite synthesis and profiling: Mimicking in vivo biotransformation reactions
Amol Chhatrapati Bisen, Sachin Nashik Sanap, Sristi Agrawal, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106722-106722
Closed Access | Times Cited: 16
Discovery of 5′′‐Chloro‐N‐[(5,6‐dimethoxypyridin‐2‐yl)methyl]‐2,2′:5′,3′′‐terpyridine‐3′‐carboxamide (MK‐1064): A Selective Orexin 2 Receptor Antagonist (2‐SORA) for the Treatment of Insomnia
Anthony J. Roecker, Swati P. Mercer, John D. Schreier, et al.
ChemMedChem (2013) Vol. 9, Iss. 2, pp. 311-322
Closed Access | Times Cited: 62
Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2?
Andrew V. Stachulski, Joshua Taujanskas, Sophie Pate, et al.
ACS Infectious Diseases (2020) Vol. 7, Iss. 6, pp. 1317-1331
Open Access | Times Cited: 46
The Metabolic Rainbow: Deep Learning Phase I Metabolism in Five Colors
Na Le Dang, Matthew K. Matlock, Tyler B. Hughes, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 3, pp. 1146-1164
Open Access | Times Cited: 40
In-Depth Understanding of the Structure-Based Reactive Metabolite Formation of Organic Functional Groups
Chunyong He, Yuchang Mao, Hong Wan
Drug Metabolism Reviews (2025), pp. 1-43
Closed Access
Significance of metabolites in the environmental risk assessment of pharmaceuticals consumed by human
Eun‐Jeong Han, Dong Soo Lee
The Science of The Total Environment (2017) Vol. 592, pp. 600-607
Closed Access | Times Cited: 45
Transglutaminase inhibitors: a patent review
Jeffrey W. Keillor, Kim Yang-Ping Apperley
Expert Opinion on Therapeutic Patents (2015) Vol. 26, Iss. 1, pp. 49-63
Closed Access | Times Cited: 43
Role of Cytochrome P450 Enzymes in the Metabolic Activation of Tyrosine Kinase Inhibitors
Klarissa D. Jackson, Rebecca Durandis, Matthew J. Vergne
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2367-2367
Open Access | Times Cited: 43
Toxicity Originating from Thiophene Containing Drugs: Exploring the Mechanism using Quantum Chemical Methods
Chaitanya K. Jaladanki, Nikhil Taxak, Rohith Varikoti, et al.
Chemical Research in Toxicology (2015) Vol. 28, Iss. 12, pp. 2364-2376
Closed Access | Times Cited: 42
Page 1 - Next Page

Scroll to top